TQB5410
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 11, 2026
Novel fourth-generation ALK inhibitor TQB5410 demonstrates potent activity against ALK-positive cancer
(EORTC-NCI-AACR 2026)
- "Abstract will be available as of 4 November (with consent of the author)"
Oncology
1 to 1
Of
1
Go to page
1